viewWeedMD Inc

North American cannabis market could be worth US$47.3bn annually by 2024

The Prohibition Partners report predicts growth in Canada – estimated at 33% annually – will likely be much slower than in the US 

cannabis flower
The consultancy suggests sales of medicinal cannabis will dwarf the recreational market in North America

New findings from a research report predict North America’s legal cannabis industry could be worth more than $47.3 billion annually by 2024. 

The North American Cannabis report, published by consultancy group Prohibition Partners, finds that despite Canada becoming the first G7 country to legalize adult-use cannabis, cannabis growth south of the border will great outstrip Canada. According to the report, the US is expected to post triple-digit growth in the industry by 2024, despite not having legalized cannabis federally. 

"Although North America's legal cannabis industry could be worth more than US$47.3 billion within the next five years, the true value of the market is likely to be much larger than current estimates," noted Daragh Anglim, Managing Director at Prohibition Partners. "This is because, contrary to the hopes of regulators, legalization is unlikely to eradicate black market sales, particularly in Canada."

READ: Buds & Duds: Cannabis stocks stumble but BevCanna shares shine on cannabis cultivation deal with Clearwater CannGrow

The report predicts the Canadian cannabis market will be worth US$3.4 billion by 2024, however, the growth in Canada - estimated at 33% annually - will likely be much slower than in the US, where it is predicting triple-digit growth. 

Medicinal cannabis is legal in 33 US states, and adult-use cannabis is legal in 11 states plus Washington DC. The report suggests sales of medicinal cannabis will dwarf the recreational market. 

"We expect the total cannabis market to be worth US$47.3 billion by 2024. By then, we believe medicinal cannabis, as well as recreational cannabis, will be legal across the region, integrated across a number of industry verticals from pharma to food."

Eyes on CBD, edibles

The report pointed to the potential of CBD lifestyle products in the upcoming year. 

"CBD has existed for quite some time in a legally grey area, and, as such, it has retained its underground status, based on word-of-mouth ‘marketing’. However, this is changing and a new industry is growing, virtually out of nowhere," noted the report's authors. "Pivotal to industry change was the passing of the 2018 Farm Bill in December 2018." 

According to the report, as western countries experience a decline in smoking rates and alcohol consumption remains flat, tobacco and beverage companies are looking to boost growth by investing in the sector – examples including deals from Constellation Brands and Altria. 

The report also pointed to the beauty market, which is seeing strong activity with a "growing number of high-end retailers adding cannabis products to their stock."

The report pointed to the fact that cannabis edibles are currently not legal across all of North America - expected to shift in October 2019 in Canada - which could signify a further expansion of the industry. 

Looking beyond North America

The report made note that the North American market plays a significant role in the wider industry.

"From an international perspective, the regulatory frameworks across Europe mirror the patchwork of legislation across the US," wrote the authors, noting that countries considering reform will likely look to learnings from Canada. "As the industry continues to develop, Europe, and indeed the international market, will continue to monitor developments in North America closely."

Contact Katie Lewis at katie@proactiveinvestors.com

Quick facts: WeedMD Inc


Price: - -

Market Cap: -

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


WeedMD signs LOI to create Consumer-Centric Product Portfolio with...

WeedMD Inc. (CVE: WMD – OTCQX: WDDMF) Interim CEO George Scorsis joined Steve Darling to share details the company has signed an LOI to acquire craft cultivator CannTx Life Sciences in an all-stock deal. Scorsis telling Proactive CannTx, which in Guelph, Ontario, is a highly regarded cultivator...

on 1/6/21

3 min read